Yourgene has earned the CE mark for its Illumina-based molecular diagnostic for Down’s syndrome and other genetic disorders.

The nucleic acid screening test, IONA Nx, assesses the likelihood that a pregnant woman’s fetus has Down’s syndrome, Edwards syndrome or Patau syndrome.

The laboratory-based test is run on the company’s NextSeq 550Dx sequencing platform. Yourgene said it expects to launch the test in the coming months.